Results 241 to 250 of about 163,047 (311)

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan   +5 more
wiley   +1 more source

Close Encounters with Art of Neuroscience 14th Edition. [PDF]

open access: yesJ Neurosci
Westerberg JA   +6 more
europepmc   +1 more source

Safety and Tolerability of Givinostat: Evidence From Real‐World and Clinical Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The aim of our study was to establish the prevalence of adverse events in a real‐world setting in boys living with Duchenne muscular dystrophy (DMD) treated with givinostat as part of an Expanded Access Program (EAP) in Italy. Methods The cohort included 90 ambulant boys, with age when treatment started between 6 and 23 years (mean ...
Marika Pane   +19 more
wiley   +1 more source

Metacognitive strategies improve self-regulation skills in expert sports coaches. [PDF]

open access: yesSci Rep
Sabaliauskas S   +3 more
europepmc   +1 more source

Evaluation of aesthetic flat closure: A scoping review. [PDF]

open access: yesJPRAS Open
Bhaskara M   +10 more
europepmc   +1 more source

Much Ado About Gender. [PDF]

open access: yesArch Sex Behav
Solander T.
europepmc   +1 more source

Home - About - Disclaimer - Privacy